Clinical science - Extended reports: Intravitreal Bevacizumab (Avastin) as Treatment for Subfoveal Choroidal Neovascularization Secondary to Pathologic Myopia
- Izumi Yamamoto,
- Adam H Rogers,
- Elias Reichel,
- Paul Yates,
- Jay S Duker









